What is Burna AI?
Burna AI is the safety and data quality platform for oncology drug development, from clinical trials through postmarket surveillance. The wedge product is CTCAE AI, an architecture for adverse event grading and multi-drug attribution that is citation-bound by design, with outputs structurally constrained to valid CTCAE grades and mandatory citations to source text and CTCAE criteria. The grading engine is twelve specialized agents operating in a cascading constraint pipeline, where each agent's output bounds the valid output space of every downstream agent. Two patents filed. The same engine processes adverse events on drugs in clinical trials and on drugs already on the market, supporting pharmacovigilance across the entire drug lifecycle. Built for regulated environments from day one: HIPAA compliant, SOC 2 certified, 21 CFR Part 11 aligned. Human-in-the-loop, always. AI suggests, clinicians decide.
- The safety and data quality platform for oncology drug development
- twelve specialized agents in a cascading constraint pipeline
- Two patents filed on the architecture
- WHO-UMC and Kramer causality algorithms for multi-drug attribution
- 42 pre-built oncology regimen profiles, 26 organ system classes, 850 CTCAE criteria
- HIPAA compliant, SOC 2 certified, 21 CFR Part 11 aligned
- Human-in-the-loop, always. AI suggests, clinicians decide